Company / Book Value per Share
ENANTA PHARMACEUTICALS INC Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$6.078
FY2025
5-year range
$6.078 / $23.036
FY2021-FY2025
Trend
-60.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 4 consecutive years, from $23.036 in FY2021 to $6.078 in FY2025.
Based on SEC 10-K filings.
$6.078 in FY2025 with a 5-year CAGR of -21.2%.
Declined from $19.212 to $6.078 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -35.4%
- 5-Year CAGR
- -21.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- ENANTA PHARMACEUTICALS INC's book value per share has declined for 4 consecutive years.
- 5-year CAGR of -21.2%, indicating a declining trend.
- In FY2025, book value per share decreased 60.2% year-over-year.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.078 | -60.2% |
| FY2024 | $15.259 | -20.6% |
| FY2023 | $19.212 | -14.7% |
| FY2022 | $22.511 | -2.3% |
| FY2021 | $23.036 | +15.3% |
| FY2020 | $19.981 | +28.5% |
| FY2019 | $15.554 | +10.2% |
| FY2018 | $14.118 | +13.8% |
| FY2017 | $12.406 | +56.2% |
| FY2016 | $7.942 | +33.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026